Shopping Cart
- Remove All
Your shopping cart is currently empty
TAK-615 is commonly used to study pulmonary fibrosis and is a negative allosteric modulator of LPA1 receptors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $69 | In Stock | |
| 5 mg | $172 | In Stock | |
| 10 mg | $273 | In Stock | |
| 25 mg | $451 | In Stock | |
| 50 mg | $636 | In Stock | |
| 100 mg | $858 | In Stock | |
| 500 mg | $1,710 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $190 | In Stock |
| Description | TAK-615 is commonly used to study pulmonary fibrosis and is a negative allosteric modulator of LPA1 receptors. |
| Targets&IC50 | LPA1 Receptor:1.7-14.5 nM (Kd) |
| In vitro | TAK-615 specifically binds to membranes expressing the human LPA1 receptor with high affinity (Kd = 1.7 ± 0.5 nM) and low affinity (Kd = 14.5 ± 12.1 nM). TAK-615 partially inhibits the LPA response (~40% at 10 μM, IC50 = 23 ± 13 nM in β-arrestin assay; 60% at 10 μM, IC50 = 91 ± 30 nM in calcium mobilization assay). [1] |
| Molecular Weight | 419.44 |
| Formula | C25H22FNO4 |
| Cas No. | 1664335-55-0 |
| Smiles | OC(=O)c1ccc(CN(CC2CC2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1 |
| Relative Density. | 1.302 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120 mg/mL (286.10 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.